Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay

AIM: The 21-gene recurrence score (RS) predicts a clinical benefit of chemotherapy for individuals with ER-positive/HER2-negative breast cancer. Using in vitro chemoresponse assay, we compared the chemosensitivity according to RS in these patients. METHOD: Among the patients with Oncotype Dx assay,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Ahn, Sung Gwe, Bae, Soong June, Yoon, Changik, Cha, Yoon Jin, Lee, Hak Woo, Lee, Seung Ah, Jeong, Joon
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2017
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5695596/
https://ncbi.nlm.nih.gov/pubmed/29117208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187679
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker